Literature DB >> 2114552

Activated CD8 binding to class I protein mediated by the T-cell receptor results in signalling.

A M O'Rourke1, J Rogers, M F Mescher.   

Abstract

The CD8 glycoprotein of T cells bind nonpolymorphic regions of class I major histocompatibility complex proteins on target cells and these interactions promote antigen recognition and signalling by the T-cell receptor. Studies using artificial membranes indicated that effective CD8/class I interaction is critical for response by alloantigen-specific cytotoxic T lymphocytes when class I protein is the only ligand on the antigen-bearing surface. But significant CD8-mediated binding of cytotoxic T lymphocytes to non-antigenic class I protein could not be detected in the absence of the alloantigen. These apparently contradictory findings indicate that CD8 binding to class I protein might be activated through the T-cell receptor and the results reported here demonstrate that this is the case. Treatment of cytotoxic T lymphocytes with soluble anti-T-cell receptor antibody activates adhesion of the cytotoxic T lymphocytes to class I, but not class II proteins. The specificity of this binding implies that it is mediated by CD8 and blocking by anti-CD8 antibodies confirmed this. Furthermore, binding of CD8 to class I protein resulted in generation of an additional signal(s) necessary to initiate response at low T-cell receptor occupancy levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114552     DOI: 10.1038/346187a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

1.  Cytotoxic T-lymphocyte interaction with fibronectin and vitronectin: activated adhesion and cosignalling.

Authors:  B Ybarrondo; A M O'Rourke; J B McCarthy; M F Mescher
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse.

Authors:  Pia P Yachi; Jeanette Ampudia; Nicholas R J Gascoigne; Tomasz Zal
Journal:  Nat Immunol       Date:  2005-06-26       Impact factor: 25.606

3.  MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells.

Authors:  Elena Catalán; Seyma Charni; Paula Jaime; Juan Ignacio Aguiló; José Antonio Enríquez; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

Review 4.  Molecular analysis of protein interactions mediating the function of the cell surface protein CD8.

Authors:  L Devine; P B Kavathas
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

5.  Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide.

Authors:  C N Levelt; E Mizoguchi; X Huang; R Zacks; A K Bhan; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 6.  Co-receptors and recognition of self at the immunological synapse.

Authors:  Nicholas R J Gascoigne; Tomasz Zal; Pia P Yachi; John A H Hoerter
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Very late antigen integrins are involved in the adhesive interaction of lymphoid cells to human gingival fibroblasts.

Authors:  S Murakami; T Saho; Y Shimabukuro; R Isoda; Y Miki; H Okada
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

8.  A distinct cytoplasmic domain of CD2 regulates ligand avidity and T-cell responsiveness to antigen.

Authors:  W C Hahn; Y Rosenstein; V Calvo; S J Burakoff; B E Bierer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Intracellular mediators regulate CD2 lateral diffusion and cytoplasmic Ca2+ mobilization upon CD2-mediated T cell activation.

Authors:  S J Liu; W C Hahn; B E Bierer; D E Golan
Journal:  Biophys J       Date:  1995-02       Impact factor: 4.033

10.  A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines.

Authors:  S Sawada; D R Littman
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.